Karyopharm Therapeutics KPTI
NASDAQ KPTI
$0.80 -0.06 (-7.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Karyopharm Therapeutics (KPTI) Depreciation & Amortization (CF) (2012 - 2025)

Updated

Karyopharm Therapeutics (KPTI) posted Depreciation & Amortization (CF) of $19,000 for Q4 2025, down 76.5% from $81,000 a year earlier and down 84.3% from the prior quarter.

Analysis

Karyopharm Therapeutics (KPTI) Depreciation & Amortization (CF) (2012 - 2025) Analysis & Trends

For FY2025, Karyopharm Therapeutics' Depreciation & Amortization (CF) came in at $296,000, down 12.9% from FY2024.

  • Annual Depreciation & Amortization (CF) has declined for six consecutive years, with a five-year compound annual growth rate of -21.2% (FY2020 to FY2025).
  • In prior years, Karyopharm Therapeutics' Depreciation & Amortization (CF) was $340,000 in FY2024 (-35.8%), $530,000 in FY2023 (-14.7%), $621,000 in FY2022 (-21.3%) and $789,000 in FY2021 (-18.8%).
  • The Q4 2025 figure stands as the lowest quarterly Depreciation & Amortization (CF) in data going back to Q4 2012.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in four of the last eight quarters, with an average decline of 13.2%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q1 2023, with growth of 63.8%; the weakest was Q4 2025, with a decline of 76.5%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $121,000 (Q3 2025), $78,000 (Q2 2025) and $78,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Karyopharm Therapeutics 25.18 Mn -201.25 Mn 32.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 19,000.00
Sep 30, 2025 121,000.00
Jun 30, 2025 78,000.00
Mar 31, 2025 78,000.00
Dec 31, 2024 81,000.00
Sep 30, 2024 83,000.00
Jun 30, 2024 91,000.00
Mar 31, 2024 85,000.00
Dec 31, 2023 77,000.00
Sep 30, 2023 80,000.00
Jun 30, 2023 83,000.00
Mar 31, 2023 290,000.00
Dec 31, 2022 113,000.00
Sep 30, 2022 182,000.00
Jun 30, 2022 149,000.00
Mar 31, 2022 177,000.00
Dec 31, 2021 139,000.00
Sep 30, 2021 186,000.00
Jun 30, 2021 229,000.00
Mar 31, 2021 235,000.00
API Access

Karyopharm Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=KPTI&period=max&api_key=YOUR_API_KEY